NIL testing revealed visible particles in Zoledronic Acid Noridem 4 mg/5 ml concentrate for solution for infusion, meaning the product does not meet quality requirements for solution appearance. Potential effects: complications after intravenous administration, embolization by particles, inflammatory reactions.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
FAQ
Related